530 related articles for article (PubMed ID: 15835921)
1. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
2. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
Sørensen BB; Rao LV
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
[TBL] [Abstract][Full Text] [Related]
3. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
4. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
[TBL] [Abstract][Full Text] [Related]
6. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
Jin J; Perera L; Stafford D; Pedersen L
J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
[TBL] [Abstract][Full Text] [Related]
7. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
Dickinson CD; Shobe J; Ruf W
J Mol Biol; 1998 Apr; 277(4):959-71. PubMed ID: 9545384
[TBL] [Abstract][Full Text] [Related]
8. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
Persson E; Olsen OH
FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
[TBL] [Abstract][Full Text] [Related]
9. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
[TBL] [Abstract][Full Text] [Related]
10. Sequential coagulation factor VIIa domain binding to tissue factor.
Osterlund M; Persson E; Carlsson U; Freskgård PO; Svensson M
Biochem Biophys Res Commun; 2005 Dec; 337(4):1276-82. PubMed ID: 16236263
[TBL] [Abstract][Full Text] [Related]
11. Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.
Olsen OH; Nielsen PF; Persson E
Biochemistry; 2004 Nov; 43(44):14096-103. PubMed ID: 15518559
[TBL] [Abstract][Full Text] [Related]
12. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
Reuning U; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
[TBL] [Abstract][Full Text] [Related]
14. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
Zhang E; St Charles R; Tulinsky A
J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the anticoagulant potency of soluble tissue factor mutants by increasing their affinity to factor VIIa.
Yang J; Lee GF; Riederer MA; Kelley RF
Thromb Haemost; 2002 Mar; 87(3):450-8. PubMed ID: 11916078
[TBL] [Abstract][Full Text] [Related]
17. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
[TBL] [Abstract][Full Text] [Related]
18. Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.
Freskgård PO; Olsen OH; Persson E
Protein Sci; 1996 Aug; 5(8):1531-40. PubMed ID: 8844844
[TBL] [Abstract][Full Text] [Related]
19. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.
Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L
Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820
[TBL] [Abstract][Full Text] [Related]
20. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.
Toso R; Pinotti M; High KA; Pollak ES; Bernardi F
Biochem J; 2002 Apr; 363(Pt 2):411-6. PubMed ID: 11931672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]